CD44v9 as a poor prognostic factor of triple-negative breast cancer treated with neoadjuvant chemotherapy
2018 · Breast Cancer · 24 citations
https://doi.org/10.1007/s12282-018-0888-y
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
17
Papers
121
Citations
6
h-index
5
i10-index
Aya Fujita is an academic researcher from Oxford Policy Management. The author has contributed to research in topics: Cancer Cells and Metastasis & Gastrointestinal Tumor Research and Treatment & Sarcoma Diagnosis and Treatment. The author has an h-index of 6, co-authored 15 publications.
https://doi.org/10.1007/s12282-018-0888-y
https://doi.org/10.1016/j.chipro.2025.100234
Click to start Chat